By Top Class Actions  |  October 3, 2012

Category: Pharmaceuticals
Follow us on Twitter and Facebook for the latest Kidney Dialysis NaturaLyte/GranuFlo Class Action Lawsuit News!
 

Manufacturer Refinances as GranuFlo Recall Lawsuits Mount

By John Curran

 

NaturaLyte heart attack class action lawsuitsGranuFlo cardiac arrest risks have dogged its German manufacturer in the form of Fresenius Medical Care lawsuits, the company that both sold the kidney dialysis drug and used it in its many kidney failure treatment centers throughout the United States. Fresenius Medical Care is expected to ask for refinancing from a number of top banks, with reasoning including both the potential for numerous Naturalyte heart attack lawsuits, as well as other drug issues the company has.

In fact, two Fresenius Medical Care drugs that reportedly kill people are in the news. In addition to GranuFlo death class action lawsuit attorneys, legal teams have noted that the German-based medical company is also making changes to its sale of propofol. The chemical is used in lethal injections in the U.S., where Fresenius has bowed out as one of just a few companies that delivers to death row. That loss in income, as well as Fresenius Medical Care lawsuits over the GranuFlo and NaturaLyte recall, are two reasons that the company is looking to get a better interest rate on $3 billion in debt.

This isn’t surprising, because as Top Class Actions has reported previously, the company is facing some problems with NaturaLyte heart attack lawsuit attorneys. Specifically, a leaked document indicated that Fresenius was aware of GranuFlo side effects in the fall of 2011, when it told doctors to cut back on its usage in its own kidney dialysis treatment centers.

While it is the largest kidney dialysis provider in the U.S., Fresenius also provided the drug to more than a hundred thousand other kidney failure patients, who weren’t informed of the risks until they met with NaturaLyte heart attack class action lawsuit attorneys, with the FDA finally issuing a serious Class 1 Recall over the summer due to those risks.

If you or someone you know with kidney failure has suffered from GranuFlo heart attack side effects, get educated. Visit the Kidney Dialysis Heart Attack, GranuFlo & NaturaLyte Recall Class Action Lawsuit Settlement Investigation to learn more about current cases and what legal options you may have. Fill out the short form there, and a qualified NaturaLyte class action lawsuit lawyer will help you with a free legal review. While the risks people were put through can be painful, suffering isn’t the only choice. Get your no-cost legal consultation to help figure out whether a remedy in court by filing a Fresenius class action lawsuit is right for you today.

 

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

 

Updated October 3rd, 2012

 

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

 

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2012 Top Class Actions® LLC
Various Trademarks held by their respective owners.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.